NRX Pharmaceuticals, Inc. (NRXP) Free cash flow 2020–2024
NRX Pharmaceuticals, Inc. (NRXP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.6MFY2024 · since FY2020: -$2.3M → -$10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$10.6M | +50.9% |
| FY2023 | -$21.7M | +45.5% |
| FY2022 | -$39.8M | -5.4% |
| FY2021 | -$37.7M | -1563.4% |
| FY2020 | -$2.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NRXP financial trends
NRXP RevenueNRXP Net incomeNRXP Net marginNRXP Gross profitNRXP Gross marginNRXP Operating incomeNRXP Operating marginNRXP Operating cash flowNRXP Capital expendituresNRXP Return on equityNRXP Stock buybacksNRXP Dividends paidNRXP Total assetsNRXP Total liabilitiesNRXP Shareholders’ equityNRXP overview →